The other study assessing the role of NF-κB in mediating systolic dysfunction in cirrhosis showed an improvement of diastolic relaxation in cardiomyocytes when its inhibitors blocked NF-κB activity, with reduction in TNF-α expression [36]. The gene discussed is NFKB1; the disease is Cirrhosis.